DUBLIN--(BUSINESS WIRE)--The "Biobanks Global Market Opportunities And Strategies To 2023" report has been added to ResearchAndMarkets.com's offering.
The biobanks market reached a value of nearly $50.3 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 6.4% to nearly $68.5 billion by 2023.
Global Biobanks Market Opportunities And Strategies To 2023 provides the strategists, marketers and senior management with the critical information they need to assess the global biobanks market.
Where is the largest and fastest growing market for the biobanks market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biobanks market opportunities and strategies to 2023 report from the author answers all these questions and many more.
This report analyses and evaluates the biobanks market, which consists of sales of biological specimens such as blood products, human tissues, cell lines nucleic acids (DNA, RNA) and other specimens through biorepositories. The report covers two periods - 2014 to 2018, the historic period and 2018 to 2023, the forecast period.
Factors such as advances in drug discovery and development, rise in funding from government and private organizations, changes in lifestyle and increasing geriatric population globally are contributing to the growth of the market. Factors such as such as stringent regulations, lack of standardization and ethical and legal issues such as informed consent and protection of participant privacy may restrain the growth of the biobanks market.
The blood products segment accounted for the largest share of the biobanks market in 2018 at $38.1 billion. The highest growth is projected to come from the human tissues and cells segment, which is forecast to grow at a CAGR of 12.3%. This growth was mainly due to greater use of blood products such as plasma and platelets for treating medical conditions and for medical research.
North America was the largest region in the biobanks market in 2018, accounting for 46.8% of the global market. It was followed by Western Europe and Asia Pacific. Going forward, the fastest growth in the biobanks market will take place in Asia Pacific, where it is forecast to grow at a CAGR of 11.1%, followed by South America where growth at a CAGR of 9.3% is expected.
The USA is the largest country in terms of value in the biobanks market. India and China are forecast to have the fastest growth, rising at CAGRs of 14.2% and 13.7% respectively.
Major players in the market include Japanese Red Cross Society (JRCS), American Red Cross, Canadian Blood Services, Biobank Graz, Shanghai Zhangjiang Biobank and others.
Major opportunities in the biobanks market will arise in the USA, where the market will gain $4,543 million in annual sales between 2018 and 2023, in China, where it will put on $3,488 million and globally, where the blood products segment will accrue $10,385 million of extra revenues in that period. To take advantage of such opportunities, biobank businesses should adopt strategies such as developing virtual banks to speed up the accessibility of biospecimens and clinical data, implementing radio frequency identification (RFID) technology to automate biospecimen sample tagging and tracking and help reduce costs and errors and building resource centers of biological samples for major diseases.
Key Topics Covered:
1. Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
7. Biobanks Market Characteristics
8. Biobanks Market - Supply Chain
9. Biobanks Market Industry Trends and Strategies
9.1.1.Development of Virtual Biobanks
9.1.2.Radio Frequency Identification (RFID) for Sample Tracking
9.1.3.Automated Sample Storage and Liquid Handling Systems in Biobanks
9.1.4.Use of Dry Storage as an Alternative by Biobanks
9.1.5.Use of Internet of Things (IOT) and Big Data Analytics in Biobanks
9.1.6.Increase in Collaborations and Partnerships
10. Biobanks Market Size and Growth
10.1. Historic Market Growth
10.2. Drivers of the Market
10.3. Restraints on the Market
10.4. Drivers of the Market
10.5. Restraints on the Market
11. Biobanks Market Regional and Country Analysis
11.1. Global Biobanks Market, By Region
11.2. Global Biobanks Market, 2014-2023, Historic and Forecast, By Region
11.3. Global Biobanks Market, By Country
11.4. Global Biobanks Market, 2014-2023, Historic and Forecast, By Country
12. Biobanks Market Segmentation
12.1. Global Biobanks Market, 2018, By Segment, Value ($ Billion)
12.2. Global Biobanks Market, 2014-2023, Historic and Forecast, By Segment
13. Global Biobanks Market Comparison with Macro Economic Factors
13.1. Global Per Capita Average Biobanks Market Expenditure
13.2. Per Capita Average Biobanks Market Expenditure, By Country
13.3. Global Biobanks Market Size, Percentage of GDP
13.4. Biobanks Market Size, Percentage of GDP, By Country
14. Asia-Pacific Biobanks Market
15. Western Europe Biobanks Market Overview
16. Eastern Europe Biobanks Market Overview
17. North America Biobanks Market Overview
18. South America Biobanks Market Overview
19. Middle East Biobanks Market Overview
20. Africa Biobanks Market Overview
21. Biobanks Market Competitive Landscape
21.1. Company Profiles
21.2. Japanese Red Cross Society
21.3. American Red Cross
21.4. Canadian Blood Services
21.5. Biobank Graz
21.6. Shanghai Zhangjiang Biobank
22. Key Mergers And Acquisitions In The Biobanks Market
22.1. Grifols Acquired Minority Stake in Interstate Blood Bank
22.2. Cryo-Cell International Acquired Cord: Use Cord Blood Bank
22.3. BioDuro Acquired Molecular Response, LLC
22.4. Roche Acquired Signature Diagnostics
22.5. Lifeblood Merged With Blood Systems
23. Market Innovations
23.1.1. Use of 3D Printing technology
23.1.2. Digitalization of biobanks
24. Opportunities And Strategies
24.1. Global Biobanks Market Opportunities
24.2. Global Biobanks Market In 2023- Countries Offering Most New Opportunities
24.3. Global Biobanks In 2023- Segments Offering Most New Opportunities
24.3.1. Blood Products
24.3.2. Cell Lines
24.3.3. Human Tissues and Cells
24.3.4. Nucleic Acids
24.4. Global Biobanks Market Strategies In 2023 - Growth Strategies
24.4.1. Market Trend Based Strategies
- American Red Cross
- Biobank Graz
- Blood Systems
- Canadian Blood Services
- Cryo-Cell International
- Interstate Blood Bank
- Japanese Red Cross Society
- Molecular Response, LLC
- Shanghai Zhangjiang Biobank
- Signature Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/qxyyu8